Get started
Author

Huiping Sheng

Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
2025 · Xiao-Dong Zhou, Li-You Lian, et al. · Journal of Hepatology · 52
PDF
Middle School Students' Body Mass Index and Physical Activity Levels in Physical Education
2011 · Zan Gao, Hyunju Oh, et al. · Research Quarterly for Exercise and Sport · 39
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD
2025 · Xiao-Dong Zhou, Yu-Ting Li, et al. · Clinical Gastroenterology and Hepatology · 36
PDF
Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study
2025 · Yu Song, Wenjing Ni, et al. · Cell Reports Medicine · 30
Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis
2021 · Yadi Li, Yan Yang, et al. · Journal of International Medical Research · 21
Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design
2018 · Shufei Zang, Jin Chen, et al. · Advances in Therapy · 20
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study
2025 · Yameng Sun, Cuisong Wu, et al. · Hepatology · 15
Haptoglobin 2-2 Genotype is Associated with More Advanced Disease in Subjects with Non-Alcoholic Steatohepatitis: A Retrospective Study
2019 · Jingxin Zhou, Jun Liu, et al. · Advances in Therapy · 13
Self-Reported Ethnicity and Genetic Ancestry in Relation to Oral Cancer and Pre-Cancer in Puerto Rico
2011 · Esther Erdei, Huiping Sheng, et al. · PLoS ONE · 8
PDF
Fibrotic MASH resolutionVCTE index to diagnose fibrotic MASH resolution and predict LREs: A global multicenter study
2025 · Gong Feng, Jérôme Boursier, et al. · Med · 3
Relationship between serum levels of transforming growth factor β_1 and hepatic fibrosis in chronic hepatitis B patients
2010 · Xiaoya Zhang, Yang Yan, et al. · Shandong yiyao · 1
Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0
2026 · Wen-Yue Liu, Li-You Lian, et al. · The American Journal of Gastroenterology
IDDF2025-ABS-0058 Longitudinal changes in fibrosis markers: monitoring stiffness/fibrosis progression and prognostic outcomes in metabolic dysfunction-associated steatotic liver disease
2025 · Xiao-Dong Zhou, Yu-Ting Li, et al.
Vitamin E (300mg) Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
2024 · Yu Song, Ming-Hua Zheng, et al. · SSRN Electronic Journal
Low Dose Vitamin E Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Investigator-Initiated Trial
2023 · Yu Song, Ming-Hua Zheng, et al. · SSRN Electronic Journal
Association of expression of peripheral CD4+CD25+CD127(low/-) regulatory T cells with liver pathology and HBV-cccDNA in patients with chronic hepatitis B
2016 · Peipei Chao, Huiping Sheng, et al.
[Effects of adefovir dipivoxil on liver pathology in patients with chronic hepatitis B].
2012 · Hui-ping Sheng, Xiao-ya Zhang, et al. · PubMed
The Relationship between Serum IFN-γ,IL-10,TGF-β1 Levels and HBV-DNA Load in Chronic Hepatitis B
2010 · Huiping Sheng · Journal of Ningxia Medical University
Analysis of the correlation between the quantities of hepatitis B virus covalently closed circular DNA and condition in chronic hepatitis B patients.
2010 · Huiping Sheng, Yand Yan, et al. · Shandong yiyao
Works count: 19
Citation count: 238
H-index: 8
I10-index: 8
Year
Topic
Type